Jinsha Site Museum Draws 120,000 Visitors During the National Day Holiday with Its Widely Praised ‘Qing Rhythm: An Invitation from Jinsha’ Event
CHENGDU, China, Oct. 15, 2025 /PRNewswire/ -- A news report from CRI…
SPJIMR Abhyudaya receives FICCI recognition for social responsibility
Abhyudaya transforms lives in Mumbai's underserved K-West ward, empowering children through mentorship,…
Signs of Change: Equipping Teachers with Tools for Inclusive Classrooms
Education Cannot Wait-funded initiative, implemented by Light for the World and Save…
Volvo Trucks: Advancing Road Safety Across Southeast Asia
Collaboration with Schools and Communities to Protect Children and Vulnerable Road Users…
New Ameriprise Research: Parents Balance Retirement and Supporting Adult Children Financially
MINNEAPOLIS--(BUSINESS WIRE)--Two-thirds (65%) of parents believe they’ll have enough money to live…
Colgate’s Bright Smiles, Bright Futures Program Celebrates Reaching Over Two Billion Children and Their Families Around the World
Over 185 million children and their families engaged pan India with significant…
Colgate Marks Historic Global Milestone: Over 2 Billion Children Benefiting from Colgate Bright Smiles, Bright Futures
Over 185 million children and families engaged pan India with significant partnerships…
Investing in Futures: Education Cannot Wait Reaches 14 Million Children in Crises Worldwide
New ECW Results Report highlights transformative education outcomes for children and adolescents…
CBM India and SBI Foundation Launch New Initiative to Empower 200 Children with Disabilities in Madhya Pradesh
The project brings essential therapy, assistive devices, and learning support to children…
![U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease](https://i3.wp.com/mms.businesswire.com/media/20250905840795/en/1247790/22/Takeda_Red_Logo_2021.jpg?w=420&resize=420,280&ssl=1 "U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease"){kind=logo}
U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce…